Conservative Management of Breast Cancer in BRCA1/2 Mutation Carriers
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 5 (1) , 37-42
- https://doi.org/10.3816/cbc.2004.n.008
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancerSeminars in Radiation Oncology, 2002
- Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast CancerNew England Journal of Medicine, 2002
- Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast CancerNew England Journal of Medicine, 2002
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic casesThe Lancet, 1997
- The genetic attributable risk of breast and ovarian cancerCancer, 1996
- Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkageCancer, 1996
- Histoprognostic grade in BRCA1-associated breast cancerThe Lancet, 1995
- Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12–21British Journal of Surgery, 1994
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990